Endometrial Cancer Care

Endometrial Cancer: Symptoms, Diagnosis, Stages & Treatment

Endometrial cancer begins in the lining of the uterus, called the endometrium. Abnormal vaginal bleeding, particularly bleeding after menopause, is an important warning symptom. Diagnosis and treatment depend on pathology, stage, tumour characteristics and individual patient factors.

What Is Endometrial Cancer?

Endometrial cancer develops from cells in the endometrium, the inner lining of the uterus. It is different from uterine sarcoma, which develops from muscle or other supporting tissues of the uterus. Identifying the exact tumour type is important because treatment and prognosis can differ.

The Endometrium and the Uterus

The uterus is a muscular organ in the female reproductive system. Its inner lining is called the endometrium. This lining normally changes during the menstrual cycle. Endometrial cancer occurs when cells in this lining grow abnormally and become malignant.

Types of Endometrial Cancer

Endometrial cancers include different histologic and molecular types. Pathology helps determine the cancer type and grade, while additional tumour testing may provide information relevant to risk assessment and treatment planning. Higher-risk tumour characteristics can require different management from lower-risk disease.

Risk Factors

Risk factors can include increasing age, obesity, endometrial hyperplasia, prolonged estrogen exposure without adequate progesterone, certain reproductive or hormonal factors, polycystic ovary syndrome in some contexts, tamoxifen exposure, family history and inherited cancer syndromes such as Lynch syndrome. Having a risk factor does not mean that a person will develop endometrial cancer.

Symptoms of Endometrial Cancer

Abnormal vaginal bleeding is an important symptom of endometrial cancer. This can include bleeding after menopause, bleeding between periods, or other unusual vaginal bleeding or discharge. Pelvic discomfort or pain may also occur. Any postmenopausal bleeding or persistent unusual bleeding should be medically evaluated.

Can Endometrial Cancer Be Prevented?

Not every case can be prevented. Risk may be influenced by weight, hormonal and reproductive factors, and inherited predisposition. People with significant hereditary risk may require individualized counselling and risk-management strategies.

Is There Screening for Endometrial Cancer?

There is no standard routine screening test recommended for the general population. A Pap test is designed primarily for cervical abnormalities and is not a routine screening test for endometrial cancer. Prompt evaluation of abnormal uterine or postmenopausal bleeding is therefore particularly important.

Diagnosis

Evaluation may include medical and menstrual or menopausal history, pelvic examination, transvaginal ultrasound and sampling of endometrial tissue. Endometrial biopsy and/or hysteroscopy with tissue sampling may be used depending on the clinical situation. Pathology confirms the diagnosis, and imaging or other investigations may be used for treatment planning and staging.

Endometrial Cancer Stages

Staging describes the extent of the cancer, including whether it is confined to the uterus or has spread to nearby or distant tissues. Endometrial cancer is broadly classified from Stage I through Stage IV, with detailed staging based on current gynecologic oncology criteria. Treatment planning should use the confirmed stage together with pathology and tumour characteristics.

Treatment of Endometrial Cancer

Treatment is individualized according to stage, histology, grade, molecular or tumour characteristics where relevant, overall health and patient preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, immunotherapy or combinations of these approaches in appropriate clinical situations.

Endometrial Cancer Surgery

Surgery is an important treatment for many patients with endometrial cancer. Depending on the case, it may include hysterectomy, removal of the fallopian tubes and ovaries, and assessment of lymph nodes when indicated. Minimally invasive or robotic/laparoscopic approaches may be considered when clinically appropriate. The surgical plan should be individualized.

Fertility-Sparing Treatment

For carefully selected patients with specific early, lower-risk disease who wish to preserve fertility, conservative treatment may sometimes be considered instead of immediate hysterectomy. This requires specialist assessment, appropriate pathology, careful counselling and close surveillance. Fertility-sparing management is not suitable for every patient.

Genetic Testing & Lynch Syndrome

Some endometrial cancers are associated with inherited cancer syndromes, particularly Lynch syndrome. Tumour testing, family history assessment, genetic counselling and germline testing may be appropriate depending on clinical findings and current guidelines. Identifying hereditary risk can also have implications for relatives.

Multidisciplinary Endometrial Cancer Care

Care may involve gynecologic oncology, pathology, radiology, medical oncology, radiation oncology, genetics and other specialists as appropriate. Multidisciplinary planning helps integrate pathology, stage, imaging, patient health and treatment options.

When to Consult a Gynecologic Oncologist

Specialist consultation may be appropriate when endometrial cancer is suspected or confirmed, when abnormal bleeding or biopsy findings require oncology assessment, when surgery or additional treatment is being planned, or when a patient wants a second opinion.

Personalized Treatment & Second Opinion

Every diagnosis should be assessed individually. Stage, pathology, tumour biology, imaging findings, general health, fertility goals where relevant and patient preferences can all influence treatment. A specialist second opinion can help clarify the diagnosis and available management options.

Frequently Asked Questions

What is endometrial cancer?
Endometrial cancer is a cancer that begins in the inner lining of the uterus, called the endometrium.
Endometrial cancer is the most common type of cancer arising in the uterus, but not all uterine cancers are endometrial cancers. Uterine sarcomas arise from different tissues and are treated differently.
Abnormal vaginal bleeding is an important warning symptom, particularly bleeding after menopause.
Yes. Postmenopausal bleeding has several possible causes, many of which are not cancer, but it should be medically evaluated.
Risk can be influenced by age, obesity, hormonal and reproductive factors, endometrial hyperplasia, some medication exposures, family history and inherited syndromes such as Lynch syndrome.
There is no standard routine screening test for the general population. People with symptoms or certain high-risk hereditary conditions may need individualized evaluation.
A Pap test is primarily used for cervical screening and is not a routine screening test for endometrial cancer.
Diagnosis commonly involves evaluation of symptoms and endometrial tissue sampling, such as an endometrial biopsy or hysteroscopy-based sampling, with pathology confirmation.
Endometrial cancer is broadly staged from Stage I to Stage IV according to how far the disease has spread. Detailed staging is determined using current gynecologic oncology criteria.
Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, immunotherapy or combinations, depending on the disease and individual patient factors.
Minimally invasive laparoscopic or robotic surgery may be appropriate for selected patients. The surgical approach depends on disease and patient factors.
In selected patients, fertility-preserving treatment may be considered. Suitability depends on tumour type, stage, extent of disease and individual circumstances.
For carefully selected patients with specific early, lower-risk disease, fertility-sparing management may sometimes be considered under specialist supervision and close follow-up.
Scroll to Top